bioMérieux Netherlands, EN

AMR is Rising — Stewardship Demands Global Leadership

One in six bacterial infections is now resistant to standard antibiotics. As antimicrobial resistance accelerates, the threat to patient safety and modern medicine grows more dire every day. The time to act is now. Antimicrobial Stewardship Centers of Excellence bring together pioneering institutions to engage in the global initiative of strengthening stewardship and diagnostic-driven care. Through partnership and shared expertise, this network helps advance the urgent fight against this silent pandemic.

Explore the AMS Centers of Excellence

News

First-Quarter 2026 Business Review

bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31, 2026. Consolidated sales totaled €984 million in the first quarter of 2026.

Discover more

Swipe for more stories

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

Discover more
bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to transform quality control. Building on the proven success of the BIOFIRE® FILMARRAY® platform, already adopted by leading global pharmaceutical companies, BIOFIRE® SPOTFIRE® introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients.

Discover more
Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats

A coalition of more than 20 international partners announced the Global One Health Diagnostics Access Compact (GO-Dx) during the G7 One Health Summit in Lyon, France. This new initiative serves as a catalyst for international leaders across different sectors to advance progress toward expanding diagnostics access, enabling early detection and better surveillance, and improving response against existing and emerging threats across human, animal, and environmental health. By aligning efforts, this group aims to strengthen global preparedness through science based One Health solutions.

Discover more

Enabling Decision-Making

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

As an antimicrobial steward

BE A GAME CHANGER

You can help sustain antibiotic efficacy for future generations with the right diagnostic tests to guide appropriate antibiotic therapy.

Discover More

In the fight against sepsis

BE A GAME CHANGER

Time is of the essence with suspected sepsis. To make rapid & accurate decisions, diagnostic is a real support. bioMérieux commits to offer a complete solution for sepsis management – from antibiotic initiation, to monitoring, to appropriate discontinuation.

Discover more

As a protector of consumer health

BE A GAME CHANGER

When you select a diagnostic partner you can trust, manufacturing safe food and beverages comes with confidence.

Discover more

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

By choosing the right partner and diagnostics solutions you can manufacture safer products, giving you confidence in the quality of your offer.

Discover more

In respiratory infections, including COVID-19

BE A GAME CHANGER

To make sure your patients don’t miss a breath, you need a partner you can count on. bioMérieux offers a comprehensive range of diagnostic tools enabling various RESPIRATORY linked infections, including primary diagnosis of SARS-CoV-2 you can rely on.

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

VITEK^® REVEAL™

The newest addition to our Sepsis Solution, VITEK^® REVEAL™ offers fast AST results to effectively and efficiently manage bloodstream infections.

VIDAS^® KUBE™

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE^® FILMARRAY^® TORCH

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

VITEK^® MS PRIME

VITEK^® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.

BIOFIRE^® SPOTFIRE^® System

The BIOFIRE^® SPOTFIRE^® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab or a throat swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care and to fight AMR.

GENE-UP^®

Our real-time PCR solution simplifies workflows, decreases cross-contamination risks, and gives you rapid results that speed up critical manufacturing decisions.

GENE-UP^® TYPER

Move from test results to actionable insights and make impactful decisions within 2 hours from an isolated colony with GENE UP® TYPER. This real-time PCR assay utilizes probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence.

VIDAS^® KUBE™ Automated Food Pathogens Detection

VIDAS® KUBE™’s adaptable automation helps your lab to be more productive, more accurate, and at the forefront of innovation—all-in-one simplifed platform.

TEMPO^® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your laboratory.

ENDONEXT^™Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

BIOFIRE^® Mycoplasma

BIOFIRE® Mycoplasma provides simple, accurate, and rapid in-house mycoplasma detection for use in testing raw materials, in-process samples, and final product release. We offer validation services designed to meet regulatory requirements—from documentation to comprehensive on-site support.

3P^® ENTERPRISE

Bridging the gap between standard processes and automation, 3P® ENTERPRISE transforms the future of environmental monitoring in the pharmaceutical industry. From sampling to trending, take control with an end-to-end, fully digitalized and automated workflow. Increase efficiency and ensure your products are safe and compliant with an innovative environmental monitoring system

VITEK^®MS PRIME

The VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing. 

Discover more

AMR is Rising — Stewardship Demands Global Leadership

News

First-Quarter 2026 Business Review

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats